Trial Profile
Clinical Trials Insight: 700033594
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 15 May 2008
Price :
$35
*
At a glance
- Drugs SEP 228425 (Primary)
- Indications Depressive disorders
- Focus Adverse reactions
- Sponsors Sunovion Pharmaceuticals
- 15 May 2008 New trial record.